Arbutus Biopharma
Earnings Date & Report
Last updated:
Arbutus Biopharma’s last earnings date was on 5 Nov 2024.
Arbutus Biopharma stock Earnings report, Estimates & History
| 2020-03-05 | -0.37 | -0.36 |
|---|---|---|
| 2020-05-11 | -0.32 | -0.25 |
| 2020-08-07 | -0.23 | -0.25 |
| 2020-11-05 | -0.2 | -0.27 |
| 2021-03-04 | -0.21 | -0.23 |
| 2021-05-05 | -0.22 | -0.21 |
| 2021-08-05 | -0.21 | -0.23 |
| 2021-11-04 | -0.24 | -0.24 |
| 2022-03-03 | -0.16 | -0.15 |
| 2022-05-05 | -0.13 | -0.11 |
| 2022-08-04 | -0.13 | -0.1 |
| 2022-11-09 | -0.12 | -0.12 |
| 2023-03-02 | -0.14 | -0.14 |
| 2023-05-04 | -0.14 | -0.1 |
| 2023-08-03 | -0.12 | -0.1 |
| 2023-11-07 | -0.12 | -0.12 |
| 2024-02-29 | -0.12 | -0.12 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Arbutus Biopharma stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 5 Nov 2024 | N/A | N/A | N/A | N/A | N/A | |
| 1 Aug 2024 | N/A | N/A | N/A | N/A | N/A | |
| 2 May 2024 | N/A | -$0.1 | N/A | 2.15M | N/A | Earnings Call Transcript |
| 29 Feb 2024 | Matched | -$0.12 | -$0.12 | 4.79M | 2.14M | Earnings Call Transcript |
| 7 Nov 2023 | Matched | -$0.12 | -$0.12 | 4.79M | 4.65M | Earnings Call Transcript |
| 3 Aug 2023 | Beat | -$0.12 | -$0.1 | 6.16M | 4.65M | Earnings Call Transcript |
| 4 May 2023 | Beat | -$0.14 | -$0.1 | 6.03M | 6.68M | Earnings Call Transcript |
| 2 Mar 2023 | Matched | -$0.14 | -$0.14 | 6.17M | 6.24M | Earnings Call Transcript |
| 9 Nov 2022 | Matched | -$0.12 | -$0.12 | N/A | 5.95M | Earnings Call Transcript |
| 4 Aug 2022 | Beat | -$0.13 | -$0.1 | N/A | 14.24M | Earnings Call Transcript |
| 5 May 2022 | Beat | -$0.13 | -$0.11 | 3.42M | 12.58M | Earnings Call Transcript |
| 3 Mar 2022 | Beat | -$0.16 | -$0.15 | 3.42M | 3.20M | Earnings Call Transcript |
| 4 Nov 2021 | Matched | -$0.24 | -$0.24 | 2.38M | 3.34M | Earnings Call Transcript |
| 5 Aug 2021 | Missed | -$0.21 | -$0.23 | 2.12M | 2.32M | Earnings Call Transcript |
| 5 May 2021 | Beat | -$0.22 | -$0.21 | 3.3M | 2.11M | Earnings Call Transcript |
| 4 Mar 2021 | Missed | -$0.21 | -$0.23 | 2.03M | 2.38M | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$0.2 | -$0.27 | 1.24M | 1.52M | |
| 7 Aug 2020 | Missed | -$0.23 | -$0.25 | 1.45M | 1.51M | Earnings Call Transcript |
| 11 May 2020 | Beat | -$0.32 | -$0.25 | 1.84M | 1.49M | Earnings Call Transcript |
| 5 Mar 2020 | Beat | -$0.37 | -$0.36 | 1.26M | 1.61M | Earnings Call Transcript |
Arbutus Biopharma Earnings report FAQs
When is Arbutus Biopharma's next Earnings date?
The company has not set the next earnings date yet. The latest Arbutus Biopharma's earnings date was on 7 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.